Suchergebnisse - "Singh, Rajendra"

PubPharm (133)

1

Component design optimization of green roof substrate layer based on the assessment of multifunctional performance

enthalten in: Environmental research | 2023

von Fei, Y. | Fu, D. | Xu, C. | +1

2

Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents

enthalten in: Clinical pharmacokinetics | 2023

von Chandasana, H. | Thapar, M. | Hayes, S. | +21

3

Impact assessment of natural variations in different weather factors on the incidence of whitefly, Bemisia tabaci Genn. and yellow vein mosaic disease in Abelmoschus esculentus (L.) Moench

enthalten in: Environmental research | 2023

von Dhole, R. | Singh, R. | Dhanapal, R. | +7

4

A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation

enthalten in: Viruses | 2023

von Firrito, C. | Bertelli, C. | Rosa, A. | +8

5

Detection of Neisseria gonorrhoeae in Genital and Extragenital Sites in Men Who Have Sex With Men in India

enthalten in: Sexually transmitted diseases | 2023

von Bhattacharya, A. | Gupta, S. | Verma, R. | +5

6

Nanoceria-GO-intercalated multicellular spheroids revascularize and salvage critical ischemic limbs through anti-apoptotic and pro-angiogenic functions

enthalten in: Biomaterials | 2023

von Bayaraa, O. | Dashnyam, K. | Singh, R. | +5

7

Phase 1 and preclinical profiling of ESM-HDAC391, a myeloid-targeted histone deacetylase inhibitor, shows enhanced pharmacology and monocytopaenia

enthalten in: British journal of clinical pharmacology | 2022

von Furze, R. | Molnar, J. | Parr, N. | +14

8

Diabetic bone regeneration with nanoceria-tailored scaffolds by recapitulating cellular microenvironment : Activating integrin/TGF-β co-signaling of MSCs while relieving oxidative stress

enthalten in: Biomaterials | 2022

von Singh, R. | Yoon, D. | Mandakhbayar, N. | +5

9

Erosion-Driven Enamel Crystallite Growth Phenomenon at the Tooth Surface In Vitro

enthalten in: ACS applied bio materials | 2022

von Cho, K. | Jo, S. | Kim, B. | +7

10

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093) : results of an open-label, phase 1-2 trial

enthalten in: The lancet. HIV | 2022

von Ruel, T. | Acosta, E. | Liu, J. | +72

CommentIn: Lancet HIV. 2022 May;9(5):e301-e302. - PMID 35489373

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]